Article

The Verge on 2022-01-25 16:19

Pfizer launches study of omicron-specific COVID-19 vaccine

Pfizer and BioNTech are testing an omicron-specific form of the COVID-19 vaccine to see if it has more durable protection against coronavirus ...

Pfizer

Related news

Pfizer starts Omicron-specific COVID-19 vaccine trial The Hindu
China , North Carolina , South Africa , United States
Pfizer, BioNTech begin study of omicron-specific COVID vaccine The Fresno Bee
Germany
Three doses of the Pfizer Covid vaccine ‘neutralises Omicron’, study suggests Shropshire Star
Wuhan
Pfizer and BioNTech begin clinical trial for Omicron-specific vaccine CNN
Moderna and Pfizer launch Omicron-specific COVID vaccine trials newatlas.com
Australia , Phase 2
Pfizer, BioNTech begin Omicron vaccine trial timesofisrael.com
China , Greece , Thessaloniki , Israel , United States
Omicron variant partly evades Pfizer vaccine protection, study shows CNN
Durban , South Africa
Omicron variant: Pfizer vaccine protects 70% against hospitalization, study finds Fox News
Gauteng , Johannesburg , Botswana , South Africa
Omicron-specific vaccine will be ready by March, Pfizer CEO says CNN
North Carolina , Fort Bragg
Pfizer says booster dose of COVID vaccine neutralizes Omicron variant New York Post
Three doses of COVID-19 vaccine neutralise Omicron variant —Pfizer punchng.com
Pfizer, BioNTech start clinical trial for vaccine targeting Omicron variant New York Post
Omicron-specific vaccine boosters are now in humans as trials begin Ars Technica
Vaccine makers have plans to make Omicron-specific booster, says Fauci Sydney Morning Herald
Germany , United Kingdom , Minnesota , Hawaii , Colorado
BSingle Dose of Pfizer Vaccine Is 85% Effective, Study Shows barrons.com
Israel
Omicron: Pfizer-BioNTech COVID-19 vaccine may only partially protect against new variant, study suggests Fox News
South Africa
Study finds Omicron variant can partially escape immunity induced by Pfizer vaccine vanguardngr.com